Business Context and Reporting Period
Origin Agritech Limited (NASDAQ: SEED), a vertically-integrated agricultural technology company based in Beijing, China, reported unaudited financial results for the second quarter of fiscal 2008 ended March 31, 2008. The company specializes in the research, development, and production of crop seeds, with a strategic focus on genetically modified (GMO) corn.
Key Financial Metrics
| Metric | Q2 2008 (RMB) | Q2 2008 (USD) | Q2 2007 (RMB) | Q2 2007 (USD) |
|---|---|---|---|---|
| Revenues | 1.56 million | 0.22 million | 1.04 million | 0.13 million |
| Gross Loss | (3.30 million) | (0.47 million) | (0.87 million) | (0.11 million) |
| Operating Loss | (37.14 million) | (5.30 million) | (31.62 million) | (4.09 million) |
| Net Loss | (29.77 million) | (4.25 million) | (31.37 million) | (4.06 million) |
| Net Loss Per Share (Diluted) | (1.30) | (0.18) | (1.34) | (0.17) |
| Cash and Equivalents | 235.18 million | 33.54 million | 162.31 million | 21.66 million |
| Working Capital | 194.73 million | 27.77 million | 294.98 million | 39.37 million |
| Deferred Revenue | 400.15 million | 57.07 million | 23.24 million | 3.10 million |
| Advances from Customers | 105.17 million | 15.00 million | 82.19 million | 10.97 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 50.54% year-over-year to RMB 1.56 million.
- Net Loss Improvement: Net loss decreased to RMB 29.77 million from RMB 31.37 million in the prior year, driven largely by a gain of RMB 4.99 million from changes in the fair value of embedded derivatives.
- Expense Increases: Operating expenses rose 10.03% to RMB 33.84 million. General and administrative expenses increased 27.80% due to higher legal and professional service fees. Selling and marketing expenses decreased slightly by 3.42%.
- Balance Sheet Shifts: Deferred revenue surged to RMB 400.15 million (up from RMB 23.24 million in Q2 2007 and RMB 112.05 million at year-end 2007), reflecting pre-paid customer orders awaiting final price determination. Cash and cash equivalents increased significantly to RMB 235.18 million.
Guidance, Outlook, and Risks
- FY2008 Guidance: Management reiterated revenue guidance of US$75 million to US$80 million and net income guidance of US$0.5 million to US$2 million. Excluding approximately US$2.7 million in non-cash interest expense from convertible debt, expected net income is US$3.0 million to US$4.5 million.
- GMO Pipeline: Phase 5 Phytase corn is on track for final approval before the end of 2008, which would mark the first GMO corn product approved for commercialization in China. Management expects a 20% price premium on GMO products, enhancing gross margins.
- Revenue Recognition: The majority of the RMB 400 million deferred revenue is expected to be recognized in the third quarter of fiscal 2008.
- Risks: The filing includes standard forward-looking statement disclaimers regarding regulatory approvals for GMO products, market transition in the Chinese corn seed sector, and potential variances in actual results due to known and unknown risks.
Investor Verification Checklist
- Verify the timing and magnitude of revenue recognition for the RMB 400 million deferred revenue balance in Q3 2008.
- Confirm the regulatory status and expected approval date for the Phase 5 Phytase corn GMO product.
- Assess the sustainability of the net loss reduction, noting the impact of the RMB 4.99 million gain from embedded derivatives.
- Review the composition of the RMB 171.5 million convertible notes and associated non-cash interest expenses.
- Monitor the trend in general and administrative expenses, which rose 27.80% year-over-year.